Lucy Muniz

Medscape Global Insights: Cardiology Trends in Latin America 🔍 Did you know that 88% of cardiologists in Latin America visit Medscape daily or weekly? 🌎❤️ The 2023 Medscape Global Insights Survey reveals that our platform is a vital resource for Latin American cardiologists, offering the latest medical news, research, and clinical guidance. Stay informed. Stay connected. #Medscape #Cardiology #LATAM #MedscapeInsights

7

In the battle against 𝐶𝑎𝑛𝑑𝑖𝑑𝑎 𝑎𝑢𝑟𝑖𝑠, accurate and timely diagnosis is pivotal. The specialized detection methods required, combined with the highly transmissible nature of 𝐶. 𝑎𝑢𝑟𝑖𝑠 presses the need for reliable outbreak detection and control. However, the complexity of identifying this multidrug-resistant pathogen presents significant challenges to healthcare professionals and diagnostic experts alike. 𝐶𝑎𝑛𝑑𝑖𝑑𝑎 𝑎𝑢𝑟𝑖𝑠 has rapidly spread across five continents, with reported cases increasing in numerous countries including the US, UK, India, South Africa, and across Europe. This escalation underscores the urgent need for robust diagnostic capabilities to effectively manage outbreaks. Key Challenges in 𝐶𝑎𝑛𝑑𝑖𝑑𝑎 𝑎𝑢𝑟𝑖𝑠 management include: 1. Microscopic distinguishing: Besides the fact that 𝐶. 𝑎𝑢𝑟𝑖𝑠 is hard to culture due to a low concentration of yeast, it is also hard to identify under a microscope. It takes a highly trained microbiologist to identify the species properly. 2. Time to culture: Current incubation methods can reach a 100% sensitivity and specificity at 36 hours of incubation with 18-24 hours as the minimum incubation period. During that time, the patient needs to be isolated and specially treated which takes up capacity. 3. Colonization: Carrying 𝐶. 𝑎𝑢𝑟𝑖𝑠 without symptoms can make you a spreader and could lead to an outbreak without notice. These people do not need to be treated but can infect others, screening is key to identify these carriers. 4. Emerging Technologies: While advancements like MALDI-TOF mass spectrometry and molecular assays offer promising solutions, access to these technologies and updated libraries remains a barrier for many laboratories. Misdiagnosis and delayed identification of 𝐶. 𝑎𝑢𝑟𝑖𝑠 can exacerbate patient outcomes, especially in high-risk settings such as hospitals and nursing homes where invasive infections can lead to severe or life-threatening infections where 1 in 3 affected die from these complications. Effective management of 𝐶𝑎𝑛𝑑𝑖𝑑𝑎 𝑎𝑢𝑟𝑖𝑠 requires collaboration and innovation in diagnostics. At PathoNostics, we recognize these challenges and are committed to advancing diagnostic solutions for fungal infections. Our CE-IVD multiplex real-time PCR kits are designed to accurately detect and differentiate fungal pathogens, with high sensitivity and specificity. Applying this specialty substantiates the development of a new screening assay to detect 𝐶. 𝑎𝑢𝑟𝑖𝑠 and aid in effective outbreak control. Stay tuned for the launch of this assay or contact us through [email protected]. Together, we can improve diagnostic capabilities and enhance patient care worldwide. Get involved in the revolution of 𝐶𝑎𝑛𝑑𝑖𝑑𝑎 𝑎𝑢𝑟𝑖𝑠 and stay tuned for more updates and solutions from PathoNostics. #CandidaAuris #DiagnosticChallenges #MolecularDiagnostics #InfectionControl #PathoNostics

33

1 comentario

🎤 Live from Biosimilars LatAm - Europe 2024! 🌍✨ Xavier presented compelling insights at the session "Emerging Technologies Addressing the Current Essential Medicine Access Gap." 🌐 📣 "Historically, biomanufacturing has been geographically concentrated, but it's time to change that and ensure global access to these products. Latin America is making strides but needs to accelerate, emphasizing the demand for affordable and sustainable bioproducts." - Xavier Frapaise, Bio-Sourcing His remarks underscore the global imperative for equitable access to biomanufactured medicines, highlighting Latin America's journey and future prospects. #Biosimilars #HealthcareAccess #Biomanufacturing #GlobalHealth #BiosimilarsLatAm #Europe2024

6

With the rise of precision medicine, market access strategies in LATAM require a nuanced approach. Understanding local diversity and regulatory frameworks is key to aligning your biomedical innovation with health system needs and patient populations. It's not just about meeting regulatory requirements; it's about ensuring that your innovations reach the right patients effectively. With precision medicine, you can make a meaningful impact on patient outcomes and the success of your healthcare solutions. Leave it in our hands #ceibohealthconsulting #HEOR #LATAM

2

Discover how Health Technology Assessment (HTA) is reshaping healthcare in Latin America! 🌍 From enhancing treatments to reducing inequalities, HTA ensures access to essential services without financial burden. 🎧Watch now to learn more and connect with BioXplore for expert strategies on improving access to life-changing treatments. #HTA #Healthcare #Innovation #Access #Equity #Policy #Transformation #BioXplore #Treatments #LatinAmerica

8

Register for the next webinar in the Health Data Passport Series to uncover rich patient data assets throughout Brazil and Latin America (LATAM). https://bit.ly/3ZkrmGz #RWD #realworlddata #DataDelivered

60

1 comentario

With its ability to detect and monitor diseases with unparalleled accuracy, immunodiagnostics stands as a cornerstone of modern medicine. Explore the impact of precision diagnostics on patient care and clinical outcomes. #Diasorin #immunodiagnostics #WorldImmunizationWeek

60

📣#ESMO24: Register Now. Time is running out. Secure your spot today. Don’t miss out on this incredible opportunity to be part of an impactful event that brings together top experts in oncology from around the world. Have you submitted an abstract? Stay tuned – notifications are going out. Late registration deadline: 7 August 2024. Why Attend? 🔬 Innovative Research: Dive into the latest advancements in #CancerResearch, early detection, and treatment. 👩‍⚕️ Expert Insights: Learn from leading #oncologists and researchers who are driving the future of cancer care. 🤝 Excellent Networking: Connect with global peers, industry leaders, and potential collaborators. 🎓 Professional Growth: ESMO-MORA: The Congress programme will be accredited with ESMO-MORA category 1 points. Don’t wait. Join us and be a part of the global effort to revolutionize cancer care. Together, we can make a difference. See you in Barcelona Register now: 🔗 https://ow.ly/c0fI50Sv9VE

66

𝐃𝐨 𝐰𝐡𝐚𝐭 𝐲𝐨𝐮 𝐬𝐚𝐲, 𝐬𝐚𝐲 𝐰𝐡𝐚𝐭 𝐲𝐨𝐮 𝐝𝐨: 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐭𝐡𝐞 𝐏𝐚𝐭𝐡𝐨𝐦𝐚𝐭𝐢𝐨𝐧 𝐒𝐭𝐚𝐧𝐝𝐚𝐫𝐝 𝐟𝐨𝐫 𝐐𝐮𝐚𝐥𝐢𝐭𝐲 𝐢𝐧 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐏𝐚𝐭𝐡𝐨𝐥𝐨𝐠𝐲 At Pathomation, we’re committed to advancing the field of Digital Pathology through innovation and quality. 𝐎𝐮𝐫 𝐦𝐢𝐬𝐬𝐢𝐨𝐧 𝐢𝐬 𝐬𝐢𝐦𝐩𝐥𝐞 𝐲𝐞𝐭 𝐢𝐦𝐩𝐚𝐜𝐭𝐟𝐮𝐥: ● Deliver best-in-class digital pathology software tailored to the needs of educators, researchers, diagnosticians, and healthcare professionals. ●Empower better treatment decisions, boost efficiency, and ultimately improve patient care. 𝐇𝐞𝐫𝐞’𝐬 𝐡𝐨𝐰 𝐰𝐞 𝐦𝐚𝐤𝐞 𝐢𝐭 𝐡𝐚𝐩𝐩𝐞𝐧: ● Robust, highly interoperable software for seamless integration. ● The complete, immediate and systematic coverage of the needs of our customers. ● Commitment to strict regulatory standards (ISO 13485:2016, CE-IVD, and FDA 510k). ● Continuous staff training and investment in innovation. A huge thank you to our incredible team and partners who make this vision a reality. Special recognition to our Quality Manager, Veerle Persy, for ensuring we uphold the highest standards every step of the way. Discover more about our commitment to quality: https://lnkd.in/ezfdZ3qx #DigitalPathology #QualityMatters #InnovationInHealthcare #Pathomation

15

1 comentario

Explore the latest insights from leading experts in the clinical lab field at the #CLINICAL24 Innovation Hub. You’ll learn how large language models and AI are changing the game in laboratory diagnostics, find practical ways to tackle staffing challenges, and see how collaboration across our industry is leading to real improvements in patient care. Visit it here: https://lnkd.in/eC7GgJ5n #Clinicalscience #AI #ChatGPT #clinicalexcellence

6

Discover strategies to accelerate clinical trials and gain valuable insights from industry experts: Our latest webinar covers innovative approaches and practical tips to speed up your #clinicaltrial processes. Learn from experienced professionals and discover how to overcome common #obstacles in clinical research. Don't miss this opportunity to enhance your trial #efficiency! ⬇️

20

1 comentario

💊 Exploring the Top Pharmaceutical Investment Areas in 2024 💊 From oncology to rare diseases, groundbreaking advancements are shaping the future of healthcare. With innovative technologies and personalized treatments, these investments are transforming millions of lives. With over 25 years of experience and 100+ successful HTAs, BioXplore supports companies in expanding their impact across Latin America, driving access to high-cost therapies and innovative medical technologies. Lead the change with us! 🌎 #PharmaInvestment #Oncology #Neurology #RareDiseases #BioXplore #MarketAccess #HealthcareInnovation #PharmaceuticalIndustry #MedicalBreakthroughs #LatinAmerica #HTA #PersonalizedMedicine #HealthTech #GlobalHealth #PharmaceuticalTrends #FutureOfHealthcare #HealthEquity #BioTech

7

🎯 Are you considering a career in International Patient Affairs? ✨ Discover the top 3 tips from Cristian Perez Gomez, Patient Advocacy Director at Blueprint Medicines.   For more insights, do not miss his full interview on Spotify! ➡️ Here is the link: https://lnkd.in/diqC4Fcs #patientaffairs #farmacose #empathy #innovation #international

26

At Sysmex, we aim to provide new value to all individuals at every stage of their lifelong #healthcarejourney through early detection of disease, disease prevention, and selection of optimal treatment. In an interview, our Chief Technology Officer, Tomokazu Yoshida, talks about his determination and his struggle to establish a new testing method in the field of #dementia, through innovative, minimally invasive blood testing technology. Read more on our Stories: https://lnkd.in/g4wtqwF2 https://lnkd.in/gFtYkyNF #AlzheimersDisease #EarlyDiagnosis #BloodTesting

154

❗LAST CHANCE to register! Don’t miss your chance to join the "Scaling Digital Health Globally: Navigating National Pathways for Patient Access" webinar, happening tomorrow, Tuesday, Nov. 19, at 10 a.m. ET. Join this webinar to learn more about the International Regulatory Pathways resources and gain actionable insights to understand and compare regulatory environments across Asia Pacific, Europe, and North America. We will explore country-specific guides, step-by-step flowcharts, and supporting resources that will help you streamline your go-to-market strategies and bring your digital health technologies (DHTs) to patients worldwide faster and more efficiently. The future of healthcare is digital, but to unlock its full potential globally, understanding the complex regulatory requirements across different jurisdictions is critical. Here’s what we’re announcing: ▪️Comprehensive international resources that give insight into the regulatory environments in key markets such as the U.S., Germany, Japan, South Korea, Australia, and more. ▪️Actionable insights that will help you prepare for the complexities of market access, pricing, reimbursement, and patient access infrastructure. ▪️Real-world evidence and case studies that showcase targeted, data-driven decision-making that lead to market entry success, helping you to optimize your DHT submissions. ▪️Resources that will help you build informed strategies for market entry and growth by aligning product development with commercial and regulatory priorities. Don’t miss this free public launch event! Register now: https://bit.ly/40phbRx Complear University of Oxford S3 Connected Health Google Health Spitzenverband Digitale Gesundheitsversorgung Università Bocconi

75

4 comentarios

Complear has worked alongside other partners on Scaling Digital Health Globally, a project by Digital Medicine Society (DiMe). Don’t miss the Digital Medicine Society (DiMe) webinar of the public launch, happening tomorrow, Tuesday, Nov. 19, at 10 a.m. ET, with our Chief Innovation Officer Miguel Amador. Learn more about the International Regulatory Pathways resources and gain actionable insights to understand and compare regulatory environments across Asia Pacific, Europe, and North America. We will explore country-specific guides, step-by-step flowcharts, and supporting resources that will help you streamline your go-to-market strategies and bring your digital health technologies (DHTs) to patients worldwide faster and more efficiently. The future of healthcare is digital, but to unlock its full potential globally, understanding the complex regulatory requirements across different jurisdictions is critical. Don’t miss this free public launch event! Register here: https://bit.ly/40phbRx University of Oxford S3 Connected Health Google Google Health Spitzenverband Digitale Gesundheitsversorgung Università Bocconi

15

1 comentario

What's cooking at Sysmex? Our group experts are working on a new project to understand how the workflow of molecular staging with OSNA compares to that of traditional methods... Are you as curious as we are? Stay tuned to learn more about it! #Sysmex #OSNA #Innovation

121

1 comentario